Literature DB >> 22901225

Mechanism of P-glycoprotein expression in the SGC7901 human gastric adenocarcinoma cell line induced by cyclooxygenase-2.

Kang-Sheng Gu1, Yu Chen.   

Abstract

OBJECTIVE: To investigate possible signal pathway involvement in multi-drug resistant P-glycoprotein (P-gp) expression induced by cyclooxygenase-2 (COX-2) in a human gastric adenocarcinoma cell line stimulated with pacliaxel (TAX).
METHODS: The effects of TAX on SGC7901 cell growth with different doses was assessed by MTT assay, along with the effects of the COX-2 selective inhibitor NS-398 and the nuclear factor-KB (NF-KB) pathway inhibitor pyrrolidine dithiocarbamate (PDTC). Influence on COX-2, NF-KB p65 and P-gp expression was determined by Western blotting.
RESULTS: TAX, NS-398 and PDTC all reduced SGC7901 growth, with dose- dependence. With increasing dose of TAX, the expression of COX-2, p65 and P-gp showed rising trends, this being reversed by NS-398. PDTC also caused decrease in expression of p65 and P-gp over time.
CONCLUSION: COX-2 may induce the expression of P-gp in SGC7901 cell line via the NF-kappa B pathway with pacliaxel stimulation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22901225     DOI: 10.7314/apjcp.2012.13.5.2379

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Functional Polymorphisms in COX-2 Gene Are Correlated with the Risk of Oral Cancer.

Authors:  Dong Li; Shu-Hong Hao; Yan Sun; Chun-Mei Hu; Zhi-Hua Ma; Zhi Ming Wang; Jie Liu; Hong Bo Liu; Ming Ye; Yu Fei Zhang; Dong Sheng Yang; Guang Shi
Journal:  Biomed Res Int       Date:  2015-04-21       Impact factor: 3.411

2.  Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance.

Authors:  Chao Shang; Lin Sun; Jiale Zhang; Bochao Zhao; Xiuxiu Chen; Huimian Xu; Baojun Huang
Journal:  Oncotarget       Date:  2017-02-28

3.  Mir-26b inhibits growth and resistance to paclitaxel chemotherapy by silencing the CDC6 gene in gastric cancer.

Authors:  Bochao Zhao; Jiale Zhang; Xiuxiu Chen; Huimian Xu; Baojun Huang
Journal:  Arch Med Sci       Date:  2018-02-07       Impact factor: 3.318

4.  The Role of Prostaglandin-Endoperoxide Synthase-2 in Chemoresistance of Non-Small Cell Lung Cancer.

Authors:  Xiao-Mian Lin; Wu Luo; Heng Wang; Rong-Zhen Li; Yi-Shan Huang; Lian-Kuai Chen; Xiao-Ping Wu
Journal:  Front Pharmacol       Date:  2019-08-08       Impact factor: 5.810

5.  Cytosolic phospholipase A2 is a key regulator of blood-brain barrier function in epilepsy.

Authors:  Anika M S Hartz; Ralf G Rempe; Emma L B Soldner; Anton Pekcec; Juli Schlichtiger; Richard Kryscio; Bjoern Bauer
Journal:  FASEB J       Date:  2019-10-29       Impact factor: 5.834

Review 6.  Molecular mechanisms of chemoresistance in gastric cancer.

Authors:  Wen-Jia Shi; Jin-Bo Gao
Journal:  World J Gastrointest Oncol       Date:  2016-09-15

7.  Contribution of FPR and TLR9 to hypoxia-induced chemoresistance of ovarian cancer cells.

Authors:  Yongqing Cai; Jian Huang; Haiyan Xing; Bin Li; Ling Li; Xianfeng Wang; Dan Peng; Jianhong Chen
Journal:  Onco Targets Ther       Date:  2018-12-28       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.